ORLANDO — In this video from the American Academy of Ophthalmology meeting, Stephen J. Kim, MD, discusses GLP-1 drugs and their retinal side effects.
GLP-1s can cause rapid progression of diabetic retinopathy, Kim said, and there are increasing concerns that they may cause nonarteritic anterior ischemic optic neuropathy.
“[GLP-1s] are widely used. They’re remarkable drugs. They transformed the landscape. The issue, though, is they have an increasing number of side effects,” Kim, professor of ophthalmology at Vanderbilt Eye Institute, said.